PATENT CLAIM ANALYSIS

Application Number: 16136920
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-05
Patent Classification: ["424", "489000"]

Abstract:
Disclosed herein is a pharmaceutical composition comprising pharmaceutical formulation of complexed Celecoxib and crystalline Celecoxib to provide fast and long lasting continuous pain management with once a daily dosing. The pharmaceutical composition has improved physicochemical properties that provide faster onset of action for acute pain relief and lower GI related side effects for acute pain relief and lower GI related side effects.

Claim (Index 32):
The pharmaceutical composition of  claim 28 , wherein said crystalline Celecoxib is micronized Celecoxib.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 97.0
- Lexical Diversity: 1.48837
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15840204', '15380219', '15496253', '15496239', '15496246']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7390894853527161
- 35 USC 102 Novelty (BERT): 0.5810106023966065
- Combined Prediction Score: 0.7232815970571052
- Mean Citation Score: 350.83076199999994
- Max Citation Score: 492.84592
- Similarity Product: 379.8923301164818

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test